Fulcrum Therapeutics, Inc. Annual Depreciation in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Fulcrum Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2018 to 2023.
  • Fulcrum Therapeutics, Inc. Depreciation for the quarter ending June 30, 2024 was $400K, a 33.3% decline year-over-year.
  • Fulcrum Therapeutics, Inc. Depreciation for the twelve months ending June 30, 2024 was $1.89M, a 19.6% decline year-over-year.
  • Fulcrum Therapeutics, Inc. annual Depreciation for 2023 was $2.17M, a 10% decline from 2022.
  • Fulcrum Therapeutics, Inc. annual Depreciation for 2022 was $2.41M, a 4.02% decline from 2021.
  • Fulcrum Therapeutics, Inc. annual Depreciation for 2021 was $2.52M, a 5.72% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.17M -$242K -10% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $2.41M -$101K -4.02% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $2.52M +$136K +5.72% Jan 1, 2021 Dec 31, 2021 10-K/A 2023-06-26
2020 $2.38M +$326K +15.9% Jan 1, 2020 Dec 31, 2020 10-K/A 2023-06-26
2019 $2.05M +$708K +52.6% Jan 1, 2019 Dec 31, 2019 10-K/A 2023-06-23
2018 $1.35M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.